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a b s t r a c t
Systemic autoimmune diseases are themselves a relevant and independent risk factor for
atherosclerosis and coronary ectasia. We describe a case of a 58-year-old Caucasian man
who was admitted to our department for unstable angina. History of asthma, paranasal
sinus abnormality, and peripheral eosinophilia given a high suspicion of Churg-Strauss
syndrome (CSS). Diagnosis was performed with 5 of the 6 American College of Rheumatology
criteria.
The knowledge that CSS is often associated with signiﬁcant coronary artery involvement
and the persistence of chest pain led us to performing immediately a coronary angiography.
Coronary angiography showed diffuse ectasic lesions, chronic occlusion of left anterior
descending artery with homocoronary collateral circulation from left circumﬂex artery and
subocclusive stenosis in the proximal tract of posterior descending artery.
The early recognition of CSS, an aggressive invasive diagnostic approach, and an early
appropriate therapy are important to prevent the progressive and permanent cardiac
damage in these patients.
In the setting of a multidisciplinary approach, careful cardiac assessment is an essential
step in CSS, even in mildly symptomatic patients.
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Churg-Strauss syndrome (CSS) is a rare form of systemic
vasculitis affecting small and medium-sized blood vessels
associated with the presence of perinuclear antineutrophil
cytoplasmatic antibodies (p-ANCA). CSS has an incidence of
0.11–2.66 cases per million per year and predominantly affects
males between the third and sixth decade.
The most typical manifestations are allergic rhinitis,
asthma, and peripheral blood eosinophilia. According to the* Corresponding author.
E-mail address: gregorydendramis@libero.it (G. Dendramis).
http://dx.doi.org/10.1016/j.ihj.2015.07.049
0019-4832/# 2015 Cardiological Society of India. Published by ElsevieAmerican College of Rheumatology (ACR), there are 6 criteria
for the diagnosis of CSS: asthma, eosinophilia, pulmonary
inﬁltrates, acute or chronic sinusitis, histological evidence of
vasculitis with extravascular eosinophils, and mononeuro-
pathy or polyneuropathy. The presence of 4 or more criteria
yields a sensitivity of 85% and a speciﬁcity of 99.7%.1
The disease can be divided into 3 phases. The initial phase
starts with allergic rhinitis, asthma, and nasal polyposis; the
second is marked by peripheral and tissue eosinophilia with
pulmonary inﬁltrates; the third is characterized by systemic
vasculitis.r B.V. All rights reserved.
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phase of CSS as vasculitic lesions in epicardial coronary
vessels and in myocardium. It is a major cause of morbidity
and mortality in these patients. CSS patients with cardiac
involvement can present ECG abnormalities (nonspeciﬁc
ST-segment and T-wave changes, conduction disturbances,
and typical pattern of pericarditis or acute coronary syn-
dromes), but in the absence of major abnormalities, cardiac
involvement could be detected in nearly 40% of patients.2
In CSS, coronary angiography can show various degrees of
stenosis, vasospasm, and coronary ectasia. Especially, coro-
nary ectasia is often reported in literature in systemic
inﬂammatory vasculitis, and it is associated with ectasia of
numerous other arterial districts such as cerebral and renal. A
wide variety of factors may inﬂuence the genesis of coronary
ectasia, particularly the overexpression of matrix metallopro-
teinases has been associated with an excessive expansive
arterial remodeling.
In these patients, coronary ectasia may have a variable
clinical presentation, often represents a coronary angiography
ﬁnding detected occasionally or following the occurrence of an
atypical chest pain, stable angina, or even of an acute coronary
syndrome.3
The involvement of cardiovascular system is responsible
for approximately 50% of all mortality in these patients and
early recognition of CSS is important to prevent permanent
organ damage, particularly coronary artery diseases.4
2. Case report
We present a case of a 58-year-old Caucasian man with
hypertension and previous ischemic stroke, admitted to ourFig. 1 – ECG at thdepartment for typical acute chest pain started while he was
walking, with spontaneous regression and associated with
paresthesia in both upper limbs.
As regards past medical history, from a young age, he was
suffering from bronchial asthma, and he was subjected to
nasal polypectomy at age twenty-ﬁve.
After the ischemic stroke had at the age of forty-eight and
labeled as cryptogenic, never have been found evidences of
vasculitis anywhere else and after he had never been subjected
to further investigation.
On examination, blood pressure was 140/80 mmHg and
heart rate was 76 bpm. The ECG showed a sinus rhythm
with ﬁrst degree atrioventricular block, left anterior fascicular
block, Q waves in DIII and aVF; T negative waves in V5,
V6 (Fig. 1). Troponin I was normal (<0.012 ng/ml) and
blood sample showed leukocytosis with 15% of eosinophil
(2.010/mL).
Transthoracic echocardiogram showed normal left ventric-
ular systolic function with ejection fraction of 55%, thickened
ventricular wall, low mitral regurgitation, and altered relaxa-
tion mitral inﬂow pattern.
History of asthma with paranasal sinus abnormality
associated with paresthesia in both upper limbs (probably
due to polyneuropathy) and peripheral eosinophilia gave a
high suspicion of CSS.
For this reason, we performed a thoracic high-resolution
computed tomography (HRCT), which revealed a bilateral
ground-glass pattern compatible with inﬂammatory lesions.
Perinuclear antineutrophil cytoplasmic antibodies (p-ANCA)
were also positive (279 AU/mL).
Diagnosis of CSS was performed with 5 of the 6 ACR criteria:
asthma, paranasal sinusitis, eosinophilia, paresthesia, and
pulmonary inﬁltrates.e admission.
Fig. 2 – Coronary angiography: ectasic lesions of right coronary artery with subocclusive stenosis in the proximal tract of
posterior descending artery (panel A) and chronic occlusion of middle-tract of left anterior descending artery with
homocoronary collateral circulation from left circumflex artery (panel B).
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was performed and showed diffuse ectasic lesions; chronic
occlusion of middle-tract of left anterior descending artery
with homocoronary collateral circulation from left circumﬂex
artery, ectasic lesions of right coronary artery with suboc-
clusive stenosis (90%) in the proximal tract of posterior
descending artery which required a PCI (percutaneous
coronary intervention) with bare metal stent (Fig. 2, panels
A and B).
On the basis of the presence of coronary ectasia, matrix
metalloproteinases plasma concentrations (MMP-2 and
MMP-9) and their tissue inhibitors (TIMP-1 and TIMP-2) were
also assessed.
An increasing of matrix metalloproteinases values and a
reduction of their tissue inhibitors were shown as reported in
literature in systemic inﬂammatory vasculitis.
The patient was also treated with steroid therapy, and
his eosinophil count dropped down to normal level with
improvement of pulmonary involvement at three months
HRCT control.
3. Conclusions
Systemic autoimmune diseases are themselves a relevant and
independent risk factor for atherosclerosis and coronary
ectasia.2,3 As reported in our case report, CSS may present
from the beginning with clinical ﬁndings of an acute coronary
syndrome (in this patient as unstable angina).
Diagnosis of CSS, the knowledge that this disease is often
associated with signiﬁcant coronary involvement (high pretestprobability of coronary artery disease) and the persistence of
chest pain led us to performing immediately a coronary
angiography.
This case underlines that the early recognition of CSS, an
aggressive invasive diagnostic approach and an early appro-
priate therapy are important to prevent the progressive and
permanent cardiac damage in these patients.
In our opinion, in the setting of a multidisciplinary
approach, careful cardiac assessment is an essential step in
CSS, even in mildly symptomatic patients.
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